Long-Term Results of Combined-Modality Therapy for Inflammatory Breast Carcinoma
- 1 December 2004
- journal article
- Published by Elsevier in Clinical Breast Cancer
- Vol. 5 (5), 358-363
- https://doi.org/10.3816/cbc.2004.n.042
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Accelerated versus standard cyclophosphamide, epirubicin and5-fluorouracil or cyclophosphamide, methotrexate and5-fluorouracil: a randomized phase III trial in locally advanced breast cancerAnnals of Oncology, 2003
- Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant ChemotherapyJournal of Clinical Oncology, 1999
- A Randomized Trial of Chemotherapy with or without Estrogenic Recruitment in Locally Advanced Breast CancerTumori Journal, 1997
- Breast conservation and prolonged chemotherapy for locally advanced breast cancer: the University of Michigan experience.Journal of Clinical Oncology, 1997
- Inflammatory breast cancer: a review.Journal of Clinical Oncology, 1992
- Results of initial doxorubicin, 5-fluorouracil, and cyclophosphamide combination chemotherapy for inflammatory carcinoma of the breastCancer, 1990
- Multimodal treatment for inflammatory breast cancerInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Initial chemoimmunotherapy in inflammatory carcinoma of the breastCancer, 1982
- Inflammatory carcinoma of the breastCancer, 1978
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958